PTSD Less Common Than Depression And Alcohol Misuse Amongst UK Troops
September 28th, 2010
They found that the prevalence of all common mental disorders was 27.2%, and PTSD symptoms, 4.8%. There were no substantial differences in the prevalence of PTSD symptoms between US and UK troops deployed to Iraq, which had been previously found. In UK troops, the most common diagnoses were alcohol abuse (18.0%) and depression/anxiety (13.5%). The […]
UGA And Emory Awarded $1.9 Million Grant To Study How Regular Aerobic Exercise May Prevent Drug Abuse Relapse
September 24th, 2010
A team of researchers at the University of Georgia and Emory University will receive $1.9 million over the next five years from the National Institutes of Health to study the neurobiological mechanisms for how regular aerobic exercise may prevent drug abuse relapse.
"Drug abuse is closely linked to stress, and one of the most challenging aspects […]
Study Findings Show Value Of Dietary Supplement SAMe In Treatment Of Adults With Major Depressive Disorders
September 24th, 2010
A new study conducted by investigators at Harvard Medical School and Massachusetts General Hospital (MGH) suggests that S-Adenosyl Methionine (SAMe), an over-the-counter dietary supplement, can be an effective, relatively well-tolerated, adjunctive treatment for adults with major depressive disorders who do not respond to their treatment with antidepressant medication. This first-of-its-kind study was published in […]
Low levels of vitamin B12 linked to Alzheimer’s - health - 21 October 2010 - New Scientist
September 23rd, 2010
People with low levels of vitamin B12 may be at greater risk of developing Alzheimer’s disease. The finding supports previous research showing large doses of B vitamins might halve the rate of brain shrinkage.
Babak Hooshmand and colleagues at the Karolinska Institute in Stockholm, Sweden, followed 271 healthy people aged 65 to 79 for seven years. […]
Study Of Combined Depression-Alcoholism Treatment Shows Higher Abstinence Rate
September 23rd, 2010
dependence treatment naltrexone produced a 54 percent abstinence rate in patients with both major
depression and alcohol dependence, whereas the rates were only 21 to 28 percent for patients taking a
placebo, sertraline only, or naltrexone only.
This study shows an important advancement in the treatment of patients who live with both alcoholism
and depression because the co-occurrence of […]